Neuralink
Neurotechnology

Neuralink

Restoring motor and sensory function through neural interface.

Trial participants
12+
Trial countries
4
Latest valuation
$9.7B
Employees
650+
The thesis

Neuralink develops implantable brain-computer interfaces designed to restore motor function and communication for people with paralysis, and is developing Blindsight, an experimental device aimed at restoring vision. The company operates through ongoing clinical trials across multiple countries.

N1 Implant

A surgical robot places ultra-thin threads with sub-millimeter precision, avoiding surface blood vessels entirely.

Milestones
2016

Company founded

Founded to develop implantable brain-computer interfaces aimed at restoring function lost to paralysis and other neurological conditions.

2023

First human clinical trial begins

The first participant received an N1 implant, beginning an ongoing series of trials now running across multiple countries.

See it in action
0:00 / 0:00

N1 Implant

The N1 implant reads signals from a thread array thinner than a human hair, placed by a purpose-built surgical robot. Trial participants use it to move a cursor, type, and play games by thought alone - no wires, fully wireless charging.

View N1 Implant
Video library
0:00 / 0:00
Clinical trial

Neuralink progress update

Official Neuralink progress and implant update.

Coming soon

Early looks at what Neuralink is building next - previews and prototypes, not yet available to buy.

0:00 / 0:00
Soon
In development

Blindsight visual demo

Visual-restoration program framing.

Gallery
Neuroscience context
Neural imaging
Lab / surgical atmosphere
Precision robotics
Frequently asked
Back this venture

Invest in Neuralink.